2013 annual financial data
Nektar Therapeutics 2013 Operating margin
Nektar Therapeutics 2013 operating margin with verified reported values.
Direct answer
Operating margin was -80.67%.
Operating income was -120,130,000 USD and net income was -162,013,000 USD.
Operating cash flow was -38,527,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 148,921,000 USD
- Operating income
- -120,130,000 USD
- Net income
- -162,013,000 USD
- Operating cash flow
- -38,527,000 USD